display:none
Skip to main content

New FREE course! DiMe is excited to share Google's Generative AI for Healthcare course with our community. Take this brief survey and begin the course specifically designed for medical professionals, administrators, and researchers who want to leverage AI in healthcare settings!

Join us for our launch, “Unlocking impact through investment: Building the business case for digital endpoints,” on Mar. 26 at 11 a.m. ET. Learn how new resources support you in measuring ROI and building your business case for digital endpoints.

Work with DiMe on an upcoming project

Integrated Evidence Plans for Digital Health Technologies

Without a structured approach to evidence generation, many promising technologies risk delayed adoption, high costs, and commercial failure.

DiMe’s recent Digital Health Industry Regulatory Needs Assessment reaffirmed the top priority from industry leaders: aligning FDA regulatory requirements with downstream payor and purchaser decision-making is critical to success. To address this, DiMe, in partnership with Peterson Health Technology Institute (PHTI), ZS Associates, and other industry leaders, developed the Integrated Evidence Plans (IEP) for Digital Health Technologies (DHTs) toolkit. This resource creates a clear, cost-effective evidence pathway to support your DHTs’ commercial success by meeting the needs of all decision-makers.

An Integrated Evidence Plan (IEP) for Digital Health Technologies (DHTs) is a dynamic, strategic framework that aligns the requirements of regulators, payers, providers, and patients by generating credible evidence about a product’s benefits, risks, and costs. It integrates stakeholder engagements, adoption pathways, and product strategies to streamline evidence generation, optimize resource allocation, and support informed decision-making, ultimately facilitating successful market entry and commercial adoption.

Use this framework to build an integrated evidence plan

We have identified the core components of an integrated evidence plan you can follow to streamline the collection of necessary evidence for all decision-makers on your path to market success. The toolkit walks you through three key stages:

Stage A

If you are in the early stages of product development, start here. This stage helps you identify your target markets, create your target product profile, and build an aligned regulatory and reimbursement strategy.

Stage B

If you’ve already identified your market and built a clinical strategy for your product, start here. This stage guides you through building comprehensive evidence packages while engaging key stakeholders.

Stage C

If you are ready to develop and execute a strong commercial strategy to ensure market adoption and long-term success, start here.

See how others have done it

Explore these successful IEP examples to learn how each organization built strategies that led to commercial success. Use them to strengthen your own approach!

Expanding access to cardiac ultrasound through AI-guided digital technology

Chronic pain management: Virtual reality (VR)-based home therapy

Our partners

This project brought together leaders in digital health product development, regulation, reimbursement, and commercial strategy with U.S. payors, purchasers, policymakers, clinicians, and patient groups.

Philanthropic Sponsor

Industry Lead Sponsor


See what others have to say about this project

Arun Bhatia | Commercial Strategy Lead, Digital Health, Rx+ Business Accelerator Astellas Pharma
Shilpa Patel | Managing Director, Innovation & Product Strategy American College of Cardiology (ACC)
Sharon Kaplow, LCSW | Vice President of Clinical Operations Feel Therapeutics
Jeff Gombala | Digital Health Consultant – An independent member of The Stem
René Quashie | Vice President, Digital Health Consumer Technology Association
Nesrine Lajmi | Evidence Lead for Clinical Insights Roche
Malcolm Brown | Early-Stage Medical Affairs Head, Global Specialty TA Astellas Pharma
Terri Kim | Head of Strategy and Corporate Development Lunit
Sean Tunis | Senior Fellow, Tufts Center for the Evaluation of Value and Risk in Health (CEVR) and Principal, Rubix Health

    Join a project

    Upcoming project:

    Assessing Mental Health Treatment Effects

    Upcoming project:

    Optimizing Treatment of Type 2 Diabetes using Sensor Data

      Join our next project

      Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

      Join the Integrated Evidence Plans project

      Join us
      Not today